BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33368871)

  • 1. Synthesis and biological evaluation of a new series of benzofuran-1,3,4-oxadiazole containing 1,2,3-triazole-acetamides as potential α-glucosidase inhibitors.
    Abedinifar F; Mohammadi-Khanaposhtani M; Asemanipoor N; Mojtabavi S; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH
    J Biochem Mol Toxicol; 2021 Apr; 35(4):e22688. PubMed ID: 33368871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New indole based hybrid oxadiazole scaffolds with N-substituted acetamides: As potent anti-diabetic agents.
    Nazir M; Abbasi MA; Aziz-Ur-Rehman ; Siddiqui SZ; Khan KM; Kanwal ; Salar U; Shahid M; Ashraf M; Arif Lodhi M; Ali Khan F
    Bioorg Chem; 2018 Dec; 81():253-263. PubMed ID: 30153590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
    Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
    Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the interaction of triaryl-dihydro-1,2,4-oxadiazoles with α-glucosidase.
    Khosravi A; Vaezi G; Hojati V; Abdi K
    Daru; 2020 Jun; 28(1):109-117. PubMed ID: 31907787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxindole based oxadiazole hybrid analogs: Novel α-glucosidase inhibitors.
    Taha M; Imran S; Rahim F; Wadood A; Khan KM
    Bioorg Chem; 2018 Feb; 76():273-280. PubMed ID: 29223804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel five-step synthetic route to 1,3,4-oxadiazole derivatives with potent α-glucosidase inhibitory potential and their in silico studies.
    Iftikhar M; Shahnawaz ; Saleem M; Riaz N; Aziz-Ur-Rehman ; Ahmed I; Rahman J; Ashraf M; Sharif MS; Khan SU; Htar TT
    Arch Pharm (Weinheim); 2019 Dec; 352(12):e1900095. PubMed ID: 31544284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzimidazole derivatives as new α-glucosidase inhibitors and in silico studies.
    Zawawi NK; Taha M; Ahmat N; Wadood A; Ismail NH; Rahim F; Azam SS; Abdullah N
    Bioorg Chem; 2016 Feb; 64():29-36. PubMed ID: 26637946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, In vitro α-Glucosidase Inhibitory Potential and Molecular Docking Studies of 2-Amino-1,3,4-Oxadiazole Derivatives.
    Ullah H; Rahim F; Taha M; Hussain R; Wadood A; Nawaz M; Wahab Z; Kanwal ; Khan KM
    Med Chem; 2020; 16(6):724-734. PubMed ID: 31195948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent α-glucosidase inhibitors.
    Saeedi M; Mohammadi-Khanaposhtani M; Asgari MS; Eghbalnejad N; Imanparast S; Faramarzi MA; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Med Chem; 2019 Dec; 27(23):115148. PubMed ID: 31679980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, In Vitro α-Glucosidase Inhibitory Activity and Molecular Docking Studies of Novel Benzothiazole-Triazole Derivatives.
    Gong Z; Peng Y; Qiu J; Cao A; Wang G; Peng Z
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28914795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors.
    Asemanipoor N; Mohammadi-Khanaposhtani M; Moradi S; Vahidi M; Asadi M; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH
    Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential α-glucosidase inhibitor: Kinetics and molecular dynamics simulation study.
    Azimi F; Ghasemi JB; Azizian H; Najafi M; Faramarzi MA; Saghaei L; Sadeghi-Aliabadi H; Larijani B; Hassanzadeh F; Mahdavi M
    Int J Biol Macromol; 2021 Jan; 166():1082-1095. PubMed ID: 33157144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel 2,4,5-triarylimidazole-1,2,3-triazole derivatives via click chemistry as α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li J; Li X
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5719-5723. PubMed ID: 27810241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of benzothiazole derivatives as a potent α-glucosidase inhibitor.
    Gollapalli M; Taha M; Javid MT; Almandil NB; Rahim F; Wadood A; Mosaddik A; Ibrahim M; Alqahtani MA; Bamarouf YA
    Bioorg Chem; 2019 Apr; 85():33-48. PubMed ID: 30599411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, molecular docking and α-glucosidase inhibition of 5-aryl-2-(6'-nitrobenzofuran-2'-yl)-1,3,4-oxadiazoles.
    Taha M; Ismail NH; Imran S; Wadood A; Rahim F; Saad SM; Khan KM; Nasir A
    Bioorg Chem; 2016 Jun; 66():117-23. PubMed ID: 27149363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, molecular docking and α-glucosidase inhibition of 2-((5,6-diphenyl-1,2,4-triazin-3-yl)thio)-N-arylacetamides.
    Wang G; Li X; Wang J; Xie Z; Li L; Chen M; Chen S; Peng Y
    Bioorg Med Chem Lett; 2017 Mar; 27(5):1115-1118. PubMed ID: 28189421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of new oxadiazole derivatives as α-glucosidase inhibitors.
    Taha M; Ismail NH; Imran S; Rokei MQB; Saad SM; Khan KM
    Bioorg Med Chem; 2015 Aug; 23(15):4155-4162. PubMed ID: 26183542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory activity evaluation and mechanistic studies of tetracyclic oxindole derivatives as α-glucosidase inhibitors.
    Sun H; Zhang Y; Ding W; Zhao X; Song X; Wang D; Li Y; Han K; Yang Y; Ma Y; Wang R; Wang D; Yu P
    Eur J Med Chem; 2016 Nov; 123():365-378. PubMed ID: 27487567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 6-hydroxyaurone analogues and evaluation of their α-glucosidase inhibitory and glucose consumption-promoting activity: Development of highly active 5,6-disubstituted derivatives.
    Sun H; Ding W; Song X; Wang D; Chen M; Wang K; Zhang Y; Yuan P; Ma Y; Wang R; Dodd RH; Zhang Y; Lu K; Yu P
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3226-3230. PubMed ID: 28651984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrano[3,2-c]quinoline Derivatives as New Class of α-glucosidase Inhibitors to Treat Type 2 Diabetes: Synthesis, in vitro Biological Evaluation and Kinetic Study.
    Heydari Z; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Mahdavi M; Ranjbar PR; Larijani B
    Med Chem; 2019; 15(1):8-16. PubMed ID: 29807519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.